Inspire Medical Systems, Inc. (INSP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4577301090
Inspire Medical Systems, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 911.98 m USD |
| Gross profit | 778.76 m USD |
| Operating income | 50.95 m USD |
| EBIT | 48.30 m USD |
| Net income | 145.42 m USD |
| Diluted EPS – continuing operations | 4.89 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
More stocks
- Arion banki hf (ARION.IC)
- Nanjing Cosmos Chemical Co Ltd (300856.SZ)
- Sumec Corp Ltd (600710.SS)
- Per Aarsleff Holding A/S (PAAL B.CO)
- Ningbo Boway Alloy Material Co Ltd (601137.SS)
- Vermilion Energy Inc (VET.TO)
- Anhui Honglu Steel Construction Group Co Ltd (002541.SZ)
- Jafron Biomedical Co Ltd (300529.SZ)
- Zymeworks Inc. (ZYME)
- Shanghai Suochen Information Technology Co. Ltd. A (688507.SS)
- LuxNet (4979.TWO)
- Hangzhou Zhongheng Electric Co Ltd (002364.SZ)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.